Back
Apellis Pharmaceuticals Stock Predictions
Economy going through a "period of transition" - Your portfolio doesn't have to
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
22
APLS
Apellis Pharmaceuticals
Last Price:
$25.10
Seasonality Move:
7.92%
7 Day Trial
ALL ACCESS PASS
$
7
The Tariff-Proof Asset in Your Pocket
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Apellis Pharmaceuticals Stock Forecast
-
Over the next 52 weeks, Apellis Pharmaceuticals has on average historically risen by 10.4% based on the past 7 years of stock performance.
-
Apellis Pharmaceuticals has risen higher in 3 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 42.86%
-
Is Apellis Pharmaceuticals Stock Undervalued?The current Apellis Pharmaceuticals [APLS] share price is $24.66. The Score for APLS is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
-
APLS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Apellis Pharmaceuticals Stock Go Up Next Year?
-
Over the next 52 weeks, Apellis Pharmaceuticals has on average historically risen by 10.4% based on the past 7 years of stock performance.
Apellis Pharmaceuticals Stock Rating
Sell
22
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals overpriced?
-
Apellis Pharmaceuticals has risen higher in 3 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 42.86%
Apellis Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
apellis.com
52-Week Data
52-Week High:
59.91
52-Week Low:
23.77
Prediction Charts
Market Cap:
3.1B
Price in USD:
24.66
Volume:
1.4M
Beta:
0.90
Technical Analysis
SMA50:
28.73
SMA100:
29.62
SMA200:
33.32
52-Wk Change:
-56.34%
Stock Predictions
-
Is Apellis Pharmaceuticals stock public?Yes, Apellis Pharmaceuticals is a publicly traded company.
-
What is the Apellis Pharmaceuticals stock quote today?The Apellis Pharmaceuticals stock price is 24.66 USD today.
-
How to buy Apellis Pharmaceuticals stock online?You can buy Apellis Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Feb-21 | 28.68 | 27.52 | 28.98 | 27.46 |
| Feb-25 | 27.68 | 26.90 | 27.68 | 26.56 |
| Feb-26 | 27.20 | 26.33 | 28.14 | 26.28 |
| Feb-27 | 26.58 | 26.00 | 27.54 | 26.00 |
| Feb-28 | 26.00 | 25.15 | 26.05 | 24.33 |
| Mar-3 | 24.80 | 24.08 | 25.33 | 23.81 |
| Mar-4 | 24.17 | 25.05 | 25.56 | 23.77 |
| Mar-5 | 25.21 | 26.01 | 26.15 | 24.75 |
| Mar-6 | 25.60 | 25.32 | 25.98 | 25.09 |
| Mar-7 | 25.00 | 25.04 | 25.49 | 24.43 |
| Mar-11 | 25.14 | 25.52 | 25.75 | 24.78 |
| Mar-12 | 25.70 | 25.18 | 25.91 | 25.15 |
| Mar-13 | 25.03 | 24.37 | 25.28 | 24.27 |
| Mar-14 | 24.63 | 24.66 | 24.81 | 24.12 |
Apellis Pharmaceuticals Earnings
Apellis Pharmaceuticals Earnings Report: Per Share Apellis Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Apellis Pharmaceuticals Forecast Revenue Growth
Apellis Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Apellis Pharmaceuticals and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.66 per share, and an increase next year of $1.09 per share.
* Apellis Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.